K. G. Jebsen Center for Genome-Directed Cancertherapy is founded with generous support from the Kristian Gerhard Jebsen Foundation. The center's goal is to identify genetic defects that sensitize solid tumors to chemotherapy and compounds that target DNA repair and to exploit such deficiencies for improved patient outcomes.
Representatives from all running centers attended the annual seminar in October 2019 at Solstrand. The seminar was hosted by the Foundation and the Center for Genome-Directed Cancerthearpy.
Our center is supported by:
Stiftelsen Kristian Gerhard Jebsen University of Bergen Haukeland University Hospital